Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: A series of 106 patients without whole-brain radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 3, 2006, Pages 809-816

  Gaudy Marqueste, Caroline ^a   Regis, Jean Marie ^b   Muracciole, Xavier ^b   Laurans, Renaud ^a   Richard, Marie Aleth ^a   Bonerandi, Jean Jacques ^b   Grob, Jean Jacques ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Brain metastasis; Gamma Knife; Melanoma; Radiosurgery; Whole brain radiotherapy

Indexed keywords

BRAIN; DISEASE CONTROL; ONCOLOGY; PATIENT MONITORING; RADIATION; SURGERY;

BRAIN METASTASIS (BM); GAMMA KNIFE; MELANOMA; RADIOSURGERY; WHOLE-BRAIN RADIOTHERAPY;

PATIENT TREATMENT;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN METASTASIS; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL TIME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOSURGERY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33646917248     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.024     Document Type: Article

References (66)

1. Sturm V., Kober B., Hover K.H., et al. Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator. Int J Radiat Oncol Biol Phys 13 (1987) 279-282
2. Sturm V., Kimmig B., Engenhardt R., et al. Radiosurgical treatment of cerebral metastases. Method, indications and results. Stereotact Funct Neurosurg 57 (1991) 7-10
3. Kihlstrom L., Karlsson B., Lindquist C., et al. Gamma Knife surgery for cerebral metastasis. Acta Neurochir (Wien) 52 Suppl (1991) 87-89
4. Somaza S., Kondziolka D., Lunsford L.D., et al. Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg 79 (1993) 661-666
5. Coffey R.J., Flickinger J.C., Lunsford L.D., et al. Solitary brain metastasis. Radiosurgery in lieu of microsurgery in 32 patients. Acta Neurochir (Wien) 52 Suppl (1991) 90-92
6. Rutigliano M.J., Lunsford L.D., Kondziolka D., et al. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery 37 (1995) 445-453
7. Vesagas T.S., Aguilar J.A., Mercado E.R., et al. Gamma Knife radiosurgery and brain metastases. Local control, survival, and quality of life. J Neurosurg 97 (2002) 507-510
8. Amendola B.E., Wolf A., Coy S., et al. Radiosurgery as palliation for brain metastases. A retrospective review of 72 patients harboring multiple lesions at presentation. J Neurosurg 97 (2002) 511-514
9. Gerosa M., Nicolato A., Foroni R., et al. Gamma knife radiosurgery for brain metastases. A primary therapeutic option. J Neurosurg 97 (2002) 515-524
10. Sampson J.H., Carter Jr. J.H., Friedman A.H., et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88 (1998) 11-20
11. Gonzalez-Martinez J., Hernandez L., Zamorano L., et al. Gamma knife radiosurgery for intracranial metastatic melanoma. A 6-year experience. J Neurosurg 97 (2002) 494-498
12. Madajewicz S., Karakousis C., West C.R., et al. Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer 53 (1984) 2550-2552
13. Mendez I.M., and Del Maestro R.F. Cerebral metastases from malignant melanoma. Can J Neurol Sci 15 (1988) 119-123
14. Saha S., Meyer M., Krementz E.T., et al. Prognostic evaluation of intracranial metastasis in malignant melanoma. Ann Surg Oncol 1 (1994) 38-44
15. Zimm S., Wampler G.L., Stablein D., et al. Intracerebral metastases in solid-tumor patients. Natural history and results of treatment. Cancer 48 (1981) 384-394
16. Douglas J.G., and Margolin K. The treatment of brain metastases from malignant melanoma. Semin Oncol 29 (2002) 518-524
17. Mori Y., Kondziolka D., Flickinger J.C., et al. Stereotactic radiosurgery for cerebral metastatic melanoma. Factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42 (1998) 581-589
18. Yu C., Chen J.C., Apuzzo M.L., et al. Metastatic melanoma to the brain. Prognostic factors after Gamma Knife radiosurgery. Int J Radiat Oncol Biol Phys 52 (2002) 1277-1287
19. Gieger M., Wu J.K., Ling M.N., et al. Response of intracranial melanoma metastases to stereotactic radiosurgery. Radiat Oncol Investig 5 (1997) 72-80
20. Mingione V., Oliveira M., Prasad D., et al. Gamma surgery for melanoma metastases in the brain. J Neurosurg 96 (2002) 544-551
21. Brown P.D., Brown C.A., Pollock B.E., et al. Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery 51 (2002) 656-665
22. Seung S.K., Sneed P.K., McDermott M.W., et al. Gamma Knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 4 (1998) 103-109
23. Li B., Yu J., Suntharalingam M., et al. Comparison of three treatment options for single brain metastasis from lung cancer. Int J Cancer 90 (2000) 37-45
24. Soffietti R., Ruda R., and Mutani R. Management of brain metastases. J Neurol 249 (2002) 1357-1369
25. Flickinger J.C. An integrated logistic formula for prediction of complications from radiosurgery. Int J Radiat Oncol Biol Phys 17 (1989) 879-885
26. Radbill A., Fiveash J., Falkenberg E., et al. Initial treatment of melanoma brain metastases using Gamma Knife radiosurgery. Cancer 101 (2004) 825-833
27. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 (1997) 745-751
28. Buchsbaum J.C., Suh J.H., Lee S.Y., et al. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma. A retrospective study. Cancer 94 (2002) 2265-2272
29. Gaspar L.E., Scott C., Murray K., et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47 (2000) 1001-1006
30. Chidel M.A., Suh J.H., Reddy C.A., et al. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 47 (2000) 993-999
31. Nieder C., Nestle U., Motaref B., et al. Prognostic factors in brain metastases. Should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?. Int J Radiat Oncol Biol Phys 46 (2000) 297-302
32. Weltman E., Salvajoli J.V., Brandt R.A., et al. Radiosurgery for brain metastases. A score index for predicting prognosis. Int J Radiat Oncol Biol Phys 46 (2000) 1155-1161
33. Lorenzoni J., Devriendt D., Massager N., et al. Radiosurgery for treatment of brain metastases. Estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 60 (2004) 218-224
34. Selek U., Chang E., Hassenbusch S., et al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiation Oncology Biol Phys 59 (2004) 1097-1106
35. Bindal A.K., Bindal R.K., Hess K.R., et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 84 (1996) 748-754
36. Adler J.R., Cox R.S., Kaplan I., et al. Stereotactic radiosurgical treatment of brain metastases. J Neurosurg 76 (1992) 444-449
37. Auchter R.M., Lamond J.P., Alexander E., et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 35 (1996) 27-35
38. Engenhart R., Kimmig B.N., Hover K.H., et al. Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71 (1993) 1353-1361
39. Flickinger J.C., Kondziolka D., Lunsford L.D., et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28 (1994) 797-802
40. Maor M.H., Dubey P., Tucker S.L., et al. Stereotactic radiosurgery for brain metastases. Results and prognostic factors. Int J Cancer 90 (2000) 157-162
41. Mehta M., Noyes W., Craig B., et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys 39 (1997) 445-454
42. Ellerhorst J., Strom E., Nardone E., et al. Whole brain irradiation for patients with metastatic melanoma. A review of 87 cases. Int J Radiat Oncol Biol Phys 49 (2001) 93-97
43. Stridsklev I.C., Hagen S., and Klepp O. Radiation therapy for brain metastases from malignant melanoma. Acta Radiol Oncol 23 (1984) 231-235
44. Cooper J.S. Radiotherapy of malignant melanoma. Dermatol Clin 3 (1985) 341-350
45. Carella R.J., Gelber R., Hendrickson F., et al. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma. Radiation Therapy Oncology Group Brain Metastases Study I and II. Cancer 45 (1980) 679-683
46. Gupta G., Robertson A.G., and MacKie R.M. Cerebral metastases of cutaneous melanoma. Br J Cancer 76 (1997) 256-259
47. Broadbent A.M., Hruby G., Tin M.M., et al. Survival following whole brain radiation treatment for cerebral metastases. An audit of 474 patients. Radiother Oncol 71 (2004) 259-265
48. Morris S.L., Low S.H., Eisen T.G., et al. A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. Br J Cancer 91 (2004) 829-833
49. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases. Phase III results of the RTOG 9508 randomised trial. Lancet 363 (2004) 1665-1672
50. Grob J.J., Regis J., Laurans R., et al. Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancerologie Cutanee. Eur J Cancer 34 (1998) 1187-1192
51. Mehta M.P., Rozental J.M., Levin A.B., et al. Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys 24 (1992) 619-625
52. Shiau C.Y., Sneed P.K., Shu H.K., et al. Radiosurgery for brain metastases. Relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 37 (1997) 375-383
53. Sneed P.K., Lamborn K.R., Forstner J.M., et al. Radiosurgery for brain metastases. Is whole brain radiotherapy necessary?. Int J Radiat Oncol Biol Phys 43 (1999) 549-558
54. Alexander II E.I., Moriarty T.M., Davis R.B., et al. Stereotactic radiosurgery for the definitive, non-invasive treatment of brain metastases. J Natl Cancer Inst 87 (1995) 34-40
55. Noel G., Simon J.M., Valery C.A., et al. Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 79 (2002) 245-255
56. Zacest A.C., Besser M., Stevens G., et al. Surgical management of cerebral metastases from melanoma. Outcome in 147 patients treated at a single institution over two decades. J Neurosurg 96 (2002) 552-558
57. Fife K.M., Colman M.H., Stevens I.C., et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 22 (2004) 1293-1300
58. Suzuki S., Omagari J., Nishio S., et al. Gamma knife radiosurgery for simultaneous multiple metastatic brain tumors. J Neurosurg 93 Suppl. 3 (2000) 30-31
59. Chen J.C., Petrovich Z., Giannotta S.L., et al. Radiosurgical salvage therapy for patients presenting with recurrence of metastatic disease to the brain. Neurosurgery 46 (2000) 860-866
60. Davey P., O'Brien P.F., Schwartz M.L., et al. A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases. Br J Neurosurg 8 (1994) 717-723
61. Margolin K., Atkins B., Thompson A., et al. Temozolomide and whole brain irradiation in melanoma metastatic to the brain. A phase II trial of the Cytokine Working Group. J Cancer Res Clin Oncol 128 (2002) 214-218
62. Falkson C.I., Falkson G., and Falkson H.C. Phase II trial of fotemustine in patients with metastatic malignant melanoma. Invest New Drugs 12 (1994) 251-254
63. Ulrich J., Gademann G., and Gollnick H. Management of cerebral metastases from malignant melanoma. Results of a combined, simultaneous treatment with fotemustine and irradiation. J Neurooncol 43 (1999) 173-178
64. DeAngelis L.M., Delattre J.Y., and Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology 39 (1989) 789-796
65. Nieder C., Schwerdtfeger K., Steudel W.I., et al. Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases. Strahlenther Onkol 174 (1998) 275-278
66. Meyers C., Smith J., Bezjak A., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium. Results of a randomized Phase III trial. J Clin Oncol 22 (2004) 157-165